Osteoarthritis Trial, Recruiting NCT06887829 Sponsor: Mayo Clinic Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT06887829
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People whose primary care provider is based at Mayo Clinic in Rochester, MN
  • People aged between 50 and 100 years old
  • People who experience at least moderate knee pain, as measured by a specific pain questionnaire called the ICOAP scale
  • People who have been diagnosed with primary knee osteoarthritis (a condition where the cartilage in the knee breaks down over time)
  • People who have not had repeated episodes of sudden warmth, redness, or swelling in the affected knee
  • People whose physical examination shows tenderness along the inner or outer joint line of the knee, in the same area where the pain is felt
  • People whose knee pain does not come from the tendons or soft tissue areas around the knee (such as below the inner knee, or the tendons connecting the thigh, calf, or kneecap muscles)
  • People whose knee X-rays, taken within the last year, show a moderate level of joint damage (graded 2 or 3 on a standard scale called Kellgren-Lawrence)
  • People who are able to complete surveys online by email

Who may not be able to join:

  • People whose knee X-rays show either very mild (grade 1) or very severe (grade 4) joint changes on the Kellgren-Lawrence scale
  • People who are pregnant, or women aged 54 or younger who could become pregnant and have not had a tubal ligation or hysterectomy, and whose partner has not had a vasectomy
  • People who have previously had surgery inside the affected knee joint
  • People who have received a corticosteroid (steroid) injection into the knee within the past 3 months, or a hyaluronan (joint lubricant) injection within the past 6 months — or within the past month if neither type of injection provided lasting relief
  • People whose current knee pain was clearly caused by an injury to that knee within the last year
  • People with a history of inflammatory joint conditions affecting that knee, such as rheumatoid arthritis, gout, pseudogout, or bleeding into the joint
  • People with a history of painful hip osteoarthritis
  • People with a history of psychosis, personality disorder, or an affective disorder (such as depression or bipolar disorder) that is not well controlled
  • People with a history of fibromyalgia (a condition causing widespread pain and fatigue)
  • People who are currently receiving active treatment for cancer
  • People who currently use opioid (strong) pain medicines, platelet-rich plasma (PRP) therapy, or acupuncture regularly for their knees

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Stephen P. Merry, M.D., Mayo Clinic

Phone: 507-422-6823

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
4 June 2025
Est. completion
28 June 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Area Under the Curve (AUC) of ICOAP Scores; Analgesic use frequency in treatment vs. sham participants

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov